MedMiraMMIRF +302.48% Days Payable is 41,546.13 as of Jan. 2026, which is 896% above its 10-year median of 4,169.27. The stock has 6 warning signs investors should review. Among 707 Biotechnology companies, MedMira ranks better than 96.75% on this metric.
MedMira's average Accounts Payable for the
three
months ended in Jan. 2026 was $2.28 Mil. MedMira's Cost of Goods Sold for the
three
months ended in Jan. 2026 was $0.01 Mil.
Hence, MedMira's Days Payable for the
three
months ended in Jan. 2026 was 41,546.13.
The historical rank and industry rank for MedMira's Days Payable or its related term are showing as below:
MMIRF'
s Days Payable Range Over the Past 10 Years
Min: 588.33 Med: 4169.27 Max: 19703.36
Current: 19703.36
During the past 13 years, MedMira's highest Days Payable was 19703.36. The lowest was 588.33. And the median was 4169.27.
MMIRF's Days Payable is ranked better than 96.75% of 707
companies
in the Biotechnology industry
Industry Median: 113.76
vs MMIRF: 19703.36
MedMira's Days Payable
increased
from Jan. 2025 (11,457.58) to Jan. 2026 (41,546.13).
It may suggest that MedMiradelayed paying its suppliers.
MedMira Days Payable Related Terms
MedMira Days Payable Historical Data
* Premium members only.
The historical data trend for MedMira's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MMIRF vs VRTX, REGN, ALNY: Days Payable Comparison
For the Biotechnology subindustry, MedMira's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MedMira Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, MedMira's Days Payable distribution charts can be found below:
* The bar in red indicates where MedMira's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
MedMira's Days Payable for the fiscal year that ended in Jul. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MedMira (MMIRF) has a Days Payable of 41,546.13 as of Jan. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on MedMira and its competitors. This is 896% above median its historical median of 4,169.27. Over the past decade, MedMira's Days Payable has ranged from 588.33 to 19,703.36. According to the industry distribution chart, MedMira ranks #23 out of 707 companies in the Biotechnology industry, placing it in the top 3.3%.
Is MedMira's Days Payable too high?
MedMira's current Days Payable of 41,546.13 is 896% above median its 10-year median of 4,169.27. Over the past 10 years, this metric has ranged from a low of 588.33 to a high of 19,703.36. The Biotechnology industry median Days Payable is 113.76. MedMira's value of 41,546.13 is 36420.9% above this industry median. Based on the distribution chart, MedMira ranks #23 out of 707 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers.
How does MedMira's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, MedMira ranks #23 out of 707 companies for Days Payable. This places MedMira in the top 3% of its industry — outperforming the majority of peers. The industry median Days Payable is 113.76. MedMira's value of 41,546.13 is 36420.9% above this benchmark. Historically, MedMira's own Days Payable has ranged from 588.33 to 19,703.36 over the past decade. While the company's 10-year median is 4,169.27 vs. the industry median of 113.76, MedMira has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.76, based on 707 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MedMira's current Days Payable of 41,546.13 is 36420.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on MedMira and its competitors. For the Biotechnology industry, the median Days Payable is 113.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MedMira's current Days Payable is 41,546.13, which is 896% above median its own 10-year median of 4,169.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedMira stock overvalued right now?
MedMira (MMIRF) has a current Days Payable of 41,546.13. The current Days Payable is 41,546.13, which is 896% above median its 10-year median of 4,169.27 and 36420.9% above the Biotechnology industry median of 113.76. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For MedMira (MMIRF), the current Days Payable is 41,546.13 as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
MedMira Inc is a biotechnology company engaged in the research, development, and manufacturing of rapid diagnostics and technologies. The company operates in one reportable operating segment, rapid diagnostic products and services. Its product line includes HIV, COVID-19, syphilis, Multiplex, Miriad RVF Toolkit, and H. pylori. The company generates revenue from North America, Europe, and other regions, with the majority generated from North America.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MMIRF has been successfully added to your 